Free Trial

Xylem (XYL) Financials

Xylem logo
$113.76 -1.88 (-1.63%)
Closing price 03:59 PM Eastern
Extended Trading
$113.88 +0.13 (+0.11%)
As of 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Xylem

Annual Income Statements for Xylem

This table shows Xylem's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
340 260 331 549 401 254 427 355 609 890 957
Consolidated Net Income / (Loss)
340 260 330 549 401 254 427 355 609 890 950
Net Income / (Loss) Continuing Operations
340 260 330 549 401 254 427 355 609 890 950
Total Pre-Tax Income
403 340 466 585 416 285 511 440 635 1,087 1,181
Total Operating Income
449 408 552 654 486 367 585 622 652 1,009 1,223
Total Gross Profit
1,404 1,462 1,847 2,026 2,046 1,830 1,975 2,084 2,717 3,212 3,475
Total Revenue
3,653 3,771 4,707 5,207 5,249 4,876 5,195 5,522 7,364 8,562 9,035
Operating Revenue
3,653 3,771 4,707 5,207 5,249 4,876 5,195 5,522 7,364 8,562 9,035
Total Cost of Revenue
2,249 2,309 2,860 3,181 3,203 3,046 3,220 3,438 4,647 5,350 5,560
Operating Cost of Revenue
2,249 2,309 2,860 3,181 3,203 3,046 3,220 3,438 4,647 5,350 5,560
Total Operating Expenses
955 1,054 1,295 1,372 1,560 1,463 1,390 1,462 2,065 2,203 2,252
Selling, General & Admin Expense
854 914 1,089 1,161 1,158 1,143 1,179 1,227 1,757 1,911 1,923
Research & Development Expense
95 110 181 189 191 187 204 206 232 230 226
Impairment Charge
- - 0.00 22 211 133 7.00 29 76 62 103
Other Special Charges / (Income)
- - - - - 0.00 0.00 - 0.00 0.00 0.00
Total Other Income / (Expense), net
-46 -68 -86 -69 -70 -82 -74 -182 -17 78 -42
Interest Expense
55 70 82 82 67 77 76 50 49 44 29
Interest & Investment Income
- - - - - - - 0.00 0.00 152 0.00
Other Income / (Expense), net
9.00 2.00 -4.00 13 -3.00 -5.00 2.00 -132 32 -30 -13
Income Tax Expense
63 80 136 36 15 31 84 85 26 197 231
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 0.00 -1.00 - - - - - 0.00 0.00 -7.00
Basic Earnings per Share
$1.88 $1.45 $1.84 $3.05 $2.23 $1.41 $2.37 $1.97 $2.81 $3.67 $3.93
Weighted Average Basic Shares Outstanding
180.89M 179.11M 179.60M 179.78M 179.99M 180.12M 180.25M 180.22M 217.01M 242.58M 243.37M
Diluted Earnings per Share
$1.87 $1.45 $1.83 $3.03 $2.21 $1.40 $2.35 $1.96 $2.79 $3.65 $3.92
Weighted Average Diluted Shares Outstanding
181.74M 180.04M 180.90M 181.13M 181.20M 181.10M 181.53M 180.98M 218.18M 243.52M 243.99M
Weighted Average Basic & Diluted Shares Outstanding
180.90M 179.30M 179.90M 180M 180.22M 180.36M 179.90M 180.28M 241.77M 243.05M 243.14M
Cash Dividends to Common per Share
$0.56 $0.62 $0.72 $0.84 $0.96 $1.04 $1.12 $1.20 $1.32 $1.44 $1.60

Quarterly Income Statements for Xylem

This table shows Xylem's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
152 266 153 194 217 326 169 226 227 335 193
Consolidated Net Income / (Loss)
152 266 153 194 217 326 167 224 226 333 189
Net Income / (Loss) Continuing Operations
152 266 153 194 217 326 167 224 226 333 189
Total Pre-Tax Income
185 210 196 247 269 375 217 299 297 368 244
Total Operating Income
191 211 209 253 280 267 231 305 334 353 244
Total Gross Profit
764 756 752 819 784 857 768 892 883 932 803
Total Revenue
2,076 2,118 2,033 2,169 2,104 2,256 2,069 2,301 2,268 2,397 2,125
Operating Revenue
2,076 2,118 2,033 2,169 2,104 2,256 2,069 2,301 2,268 2,397 2,125
Total Cost of Revenue
1,312 1,362 1,281 1,350 1,320 1,399 1,301 1,409 1,385 1,465 1,322
Operating Cost of Revenue
1,312 1,362 1,281 1,350 1,320 1,399 1,301 1,409 1,385 1,465 1,322
Total Operating Expenses
573 545 543 566 504 590 537 587 549 579 559
Selling, General & Admin Expense
491 466 474 485 445 507 460 503 474 486 472
Research & Development Expense
61 60 59 58 55 58 56 58 52 60 56
Impairment Charge
21 19 10 23 4.00 25 21 26 23 33 31
Total Other Income / (Expense), net
-6.00 -1.00 -13 -6.00 -11 108 -14 -6.00 -37 15 0.00
Interest Expense
14 14 14 11 10 9.00 8.00 9.00 6.00 6.00 4.00
Other Income / (Expense), net
8.00 13 1.00 5.00 -1.00 -35 -6.00 3.00 -31 21 4.00
Income Tax Expense
33 -56 43 53 52 49 50 75 71 35 55
Net Income / (Loss) Attributable to Noncontrolling Interest
- - 0.00 0.00 0.00 - -2.00 -2.00 -1.00 -2.00 -4.00
Basic Earnings per Share
$0.63 $1.18 $0.63 $0.80 $0.89 $1.35 $0.69 $0.93 $0.93 $1.38 $0.79
Weighted Average Basic Shares Outstanding
240.87M 217.01M 241.85M 242.57M 242.93M 242.58M 243.11M 243.40M 243.45M 243.37M 242.77M
Diluted Earnings per Share
$0.63 $1.17 $0.63 $0.80 $0.89 $1.33 $0.69 $0.93 $0.93 $1.37 $0.79
Weighted Average Diluted Shares Outstanding
242.19M 218.18M 243.02M 243.54M 243.75M 243.52M 243.78M 243.86M 244.09M 243.99M 243.36M
Weighted Average Basic & Diluted Shares Outstanding
241.08M 241.77M 242.45M 242.89M 242.94M 243.05M 243.35M 243.41M 243.47M 243.14M 237.69M
Cash Dividends to Common per Share
$0.33 - $0.36 $0.36 - - $0.40 $0.40 - - $0.43

Annual Cash Flow Statements for Xylem

This table details how cash moves in and out of Xylem's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
17 -372 106 -118 428 1,151 -526 -405 75 102 358
Net Cash From Operating Activities
464 497 686 586 839 824 538 596 837 1,263 1,241
Net Cash From Continuing Operating Activities
464 497 686 586 839 824 538 596 837 1,263 1,241
Net Income / (Loss) Continuing Operations
340 260 330 549 401 254 427 355 609 890 950
Consolidated Net Income / (Loss)
340 260 330 549 401 254 427 355 609 890 950
Depreciation Expense
88 87 109 117 117 117 118 111 193 258 267
Amortization Expense
45 64 125 144 140 134 127 125 243 304 308
Non-Cash Adjustments To Reconcile Net Income
-1.00 27 42 20 229 178 17 182 112 -9.00 166
Changes in Operating Assets and Liabilities, net
-8.00 59 80 -244 -48 141 -151 -177 -320 -180 -450
Net Cash From Investing Activities
-132 -1,886 -181 -643 -231 -169 -183 -191 -628 -482 -471
Net Cash From Continuing Investing Activities
-132 -1,886 -181 -643 -231 -169 -183 -191 -628 -482 -471
Purchase of Property, Plant & Equipment
-117 -124 -170 -237 -226 -183 -208 -208 -271 -321 -331
Acquisitions
-18 -1,782 -33 -433 -18 - -5.00 -3.00 -476 -193 -200
Purchase of Investments
0.00 0.00 -11 -11 -7.00 -200 0.00 -21 -58 -17 -49
Sale of Property, Plant & Equipment
0.00 1.00 1.00 - - - 3.00 4.00 1.00 4.00 17
Divestitures
1.00 0.00 16 22 0.00 0.00 10 1.00 105 11 49
Sale and/or Maturity of Investments
0.00 0.00 10 11 20 212 14 33 29 35 43
Other Investing Activities, net
2.00 19 6.00 5.00 0.00 2.00 3.00 3.00 42 -1.00 0.00
Net Cash From Financing Activities
-262 1,034 -421 -40 -177 473 -855 -790 -157 -615 -501
Net Cash From Continuing Financing Activities
-262 1,034 -421 -40 -177 473 -855 -790 -157 -615 -501
Repayment of Debt
-4.00 -688 -282 -172 -257 -642 -603 -529 -173 -313 -116
Repurchase of Common Equity
-179 -4.00 -25 -59 -40 -61 -68 -52 -25 -20 -15
Payment of Dividends
-102 -112 -130 -152 -174 -188 -203 -217 -299 -350 -391
Issuance of Debt
0.00 1,814 0.00 336 281 1,344 0.00 0.00 278 1.00 1.00
Other Financing Activities, net
23 24 16 7.00 13 20 19 8.00 62 67 20
Effect of Exchange Rate Changes
-53 -17 22 -21 -3.00 23 -26 -20 23 -53 90
Other Net Changes in Cash
- - - - - - - - 0.00 -11 -1.00
Cash Interest Paid
52 49 78 78 77 77 99 76 69 67 61
Cash Income Taxes Paid
75 78 57 75 107 41 83 91 211 219 267

Quarterly Cash Flow Statements for Xylem

This table details how cash moves in and out of Xylem's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-3.00 314 -72 -132 174 132 80 111 21 288 -463
Net Cash From Operating Activities
373 455 89 288 311 575 33 305 360 543 108
Net Cash From Continuing Operating Activities
373 455 89 288 311 575 200 305 360 543 301
Net Income / (Loss) Continuing Operations
152 266 153 194 217 326 336 226 222 333 382
Consolidated Net Income / (Loss)
152 266 153 194 217 326 336 226 222 333 382
Depreciation Expense
63 61 61 62 68 67 68 69 64 66 65
Amortization Expense
84 76 73 83 73 75 77 76 78 77 75
Non-Cash Adjustments To Reconcile Net Income
24 30 31 33 18 -91 54 34 69 9.00 32
Changes in Operating Assets and Liabilities, net
50 22 -229 -84 -65 198 -335 -100 -73 58 -253
Net Cash From Investing Activities
-50 -89 -51 -77 -65 -289 -15 -125 -189 -142 -76
Net Cash From Continuing Investing Activities
-50 -89 -51 -77 -65 -289 -15 -125 -189 -142 -76
Purchase of Property, Plant & Equipment
-74 -94 -74 -73 -74 -100 -71 -98 -79 -83 -90
Acquisitions
-2.00 1.00 0.00 - -2.00 -190 -7.00 -39 -108 -45 -1.00
Purchase of Investments
-1.00 - -2.00 -5.00 -1.00 -3.00 -1.00 - -26 -23 0.00
Sale of Property, Plant & Equipment
2.00 -1.00 1.00 2.00 - 1.00 5.00 - 10 2.00 1.00
Divestitures
12 2.00 11 - - - 48 2.00 -2.00 1.00 0.00
Sale and/or Maturity of Investments
12 3.00 13 5.00 12 5.00 12 9.00 15 7.00 14
Other Investing Activities, net
1.00 - 0.00 1.00 - -2.00 -1.00 1.00 1.00 -1.00 0.00
Net Cash From Financing Activities
-306 -86 -82 -337 -101 -95 -116 -128 -138 -119 -683
Net Cash From Continuing Financing Activities
-306 -86 -82 -337 -101 -95 -116 -128 -138 -119 -683
Repayment of Debt
-157 -10 -12 -277 -15 -9.00 -12 -35 -40 -29 -14
Repurchase of Common Equity
-1.00 -15 -15 -3.00 -1.00 -1.00 -13 - -1.00 -1.00 -563
Payment of Dividends
-80 -80 -88 -87 -88 -87 -98 -98 -97 -98 -106
Issuance of Debt
-73 2.00 0.00 - - 1.00 1.00 3.00 -3.00 - 0.00
Other Financing Activities, net
5.00 17 33 30 3.00 1.00 6.00 2.00 3.00 9.00 0.00
Other Net Changes in Cash
- - 0.00 - - - 11 - -11 -1.00 -5.00
Cash Interest Paid
13 26 13 23 13 18 12 20 11 18 11
Cash Income Taxes Paid
24 52 39 71 50 59 37 138 33 59 28

Annual Balance Sheets for Xylem

This table presents Xylem's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
4,657 6,474 6,860 7,222 7,710 8,750 8,276 7,952 16,112 16,493 17,634
Total Current Assets
2,005 1,839 2,071 2,094 2,450 3,523 3,160 3,012 3,884 4,098 4,641
Cash & Equivalents
680 308 414 296 724 1,875 1,349 944 1,019 1,121 1,479
Accounts Receivable
749 843 956 1,031 1,036 923 953 1,096 1,617 1,668 1,759
Inventories, net
433 522 524 595 539 558 700 799 1,018 996 983
Prepaid Expenses
143 166 177 172 151 167 158 173 230 236 244
Other Current Nonoperating Assets
- - - - - - - - 0.00 77 176
Plant, Property, & Equipment, net
439 616 643 656 658 657 644 630 1,169 1,152 1,159
Total Noncurrent Assets
2,213 4,019 4,146 4,472 4,602 4,570 4,472 4,310 11,059 11,243 11,834
Goodwill
1,584 2,632 2,768 2,976 2,839 2,854 2,792 2,719 7,587 7,980 8,332
Intangible Assets
435 1,201 1,168 1,232 1,174 1,093 1,016 930 2,529 2,379 2,272
Other Noncurrent Operating Assets
194 186 210 264 589 623 664 661 943 884 1,230
Total Liabilities & Shareholders' Equity
4,657 6,474 6,860 7,222 7,710 8,750 8,276 7,952 16,112 16,493 17,634
Total Liabilities
2,573 4,267 4,341 4,440 4,743 5,774 5,050 4,449 5,936 5,611 5,885
Total Current Liabilities
823 1,238 1,100 1,389 1,501 1,956 1,391 1,590 2,205 2,336 2,856
Short-Term Debt
78 260 0.00 257 276 600 - 0.00 16 38 534
Accounts Payable
338 457 549 586 597 569 639 723 968 1,006 1,013
Accrued Expenses
407 521 551 546 628 787 752 867 1,221 1,271 1,237
Other Current Nonoperating Liabilities
- - - - - - - - 0.00 21 72
Total Noncurrent Liabilities
1,750 3,029 3,241 3,051 3,242 3,818 3,659 2,859 3,731 3,275 3,029
Long-Term Debt
1,196 2,108 2,200 2,051 2,040 2,484 2,440 1,880 2,268 1,978 1,408
Noncurrent Deferred & Payable Income Tax Liabilities
118 352 252 303 310 242 287 222 557 497 405
Noncurrent Employee Benefit Liabilities
335 408 442 400 445 519 438 286 344 304 317
Other Noncurrent Operating Liabilities
101 161 347 297 447 573 494 471 562 496 899
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - - - - - - - 0.00 235 258
Total Equity & Noncontrolling Interests
2,084 2,207 2,519 2,782 2,967 2,976 3,226 3,503 10,176 10,647 11,491
Total Preferred & Common Equity
2,084 2,190 2,503 2,768 2,957 2,968 3,218 3,494 10,166 10,642 11,480
Total Common Equity
2,084 2,190 2,503 2,768 2,957 2,968 3,218 3,494 10,166 10,642 11,480
Common Stock
1,836 1,878 1,914 1,952 1,993 2,039 2,091 2,136 8,567 8,690 8,762
Retained Earnings
885 1,033 1,227 1,639 1,866 1,930 2,154 2,292 2,601 3,140 3,706
Treasury Stock
-399 -403 -428 -487 -527 -588 -656 -708 -733 -753 -768
Accumulated Other Comprehensive Income / (Loss)
-238 -318 -210 -336 -375 -413 -371 -226 -269 -435 -220
Noncontrolling Interest
0.00 17 16 14 10 8.00 8.00 9.00 10 5.00 11

Quarterly Balance Sheets for Xylem

This table presents Xylem's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
16,097 15,905 16,112 15,924 15,765 16,046 16,493 16,559 17,191 17,295 16,954
Total Current Assets
3,735 3,651 3,884 3,893 3,781 4,013 4,098 4,084 4,369 4,441 4,030
Cash & Equivalents
708 705 1,019 947 815 989 1,121 1,059 1,170 1,191 808
Accounts Receivable
1,659 1,653 1,617 1,641 1,675 1,707 1,668 1,743 1,837 1,803 1,796
Inventories, net
1,143 1,080 1,018 1,039 1,057 1,091 996 1,022 1,071 1,035 991
Prepaid Expenses
225 213 230 266 234 226 236 260 283 254 243
Other Current Nonoperating Assets
- - 0.00 - - - 77 0.00 8.00 158 192
Plant, Property, & Equipment, net
1,144 1,132 1,169 1,141 1,144 1,158 1,152 1,157 1,189 1,141 1,151
Total Noncurrent Assets
11,218 11,122 11,059 10,890 10,840 10,875 11,243 11,318 11,633 11,713 11,773
Goodwill
7,108 7,149 7,587 7,509 7,509 7,593 7,980 8,061 8,237 8,280 8,292
Intangible Assets
3,188 3,039 2,529 2,454 2,374 2,326 2,379 2,332 2,354 2,319 2,213
Other Noncurrent Operating Assets
922 934 943 927 957 956 884 925 1,042 1,114 1,268
Total Liabilities & Shareholders' Equity
16,097 15,905 16,112 15,924 15,765 16,046 16,493 16,559 17,191 17,295 16,954
Total Liabilities
6,187 5,964 5,936 5,721 5,417 5,446 5,611 5,505 5,882 5,850 5,725
Total Current Liabilities
2,282 2,120 2,205 2,331 2,042 2,052 2,336 2,166 2,301 2,269 2,755
Short-Term Debt
240 17 16 285 17 17 38 41 68 49 531
Accounts Payable
968 943 968 948 940 930 1,006 958 1,047 968 969
Accrued Expenses
1,074 1,160 1,221 1,098 1,085 1,105 1,271 1,167 1,186 1,172 1,182
Other Current Nonoperating Liabilities
- - 0.00 - - - 21 0.00 0.00 80 73
Total Noncurrent Liabilities
3,905 3,844 3,731 3,390 3,375 3,394 3,275 3,339 3,581 3,581 2,970
Long-Term Debt
2,267 2,253 2,268 1,985 1,981 1,977 1,978 1,974 1,928 1,913 1,407
Noncurrent Deferred & Payable Income Tax Liabilities
738 724 557 558 552 535 497 486 427 492 437
Noncurrent Employee Benefit Liabilities
293 281 344 323 325 332 304 317 340 323 308
Other Noncurrent Operating Liabilities
607 586 562 524 517 550 496 562 886 853 818
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - 0.00 - - - 235 232 228 226 249
Total Equity & Noncontrolling Interests
9,910 9,941 10,176 10,203 10,348 10,600 10,647 10,822 11,081 11,219 10,980
Total Preferred & Common Equity
9,899 9,930 10,166 10,195 10,341 10,593 10,642 10,816 11,074 11,207 10,972
Total Common Equity
9,899 9,930 10,166 10,195 10,341 10,593 10,642 10,816 11,074 11,207 10,972
Common Stock
8,498 8,532 8,567 8,621 8,663 8,676 8,690 8,708 8,723 8,738 8,775
Retained Earnings
2,344 2,416 2,601 2,667 2,774 2,902 3,140 3,211 3,339 3,469 3,794
Treasury Stock
-717 -718 -733 -748 -751 -753 -753 -766 -766 -767 -1,368
Accumulated Other Comprehensive Income / (Loss)
-226 -300 -269 -345 -345 -232 -435 -337 -222 -233 -229
Noncontrolling Interest
11 11 10 8.00 7.00 7.00 5.00 6.00 7.00 12 8.00

Annual Metrics And Ratios for Xylem

This table displays calculated financial ratios and metrics derived from Xylem's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-6.72% 3.23% 24.82% 10.62% 0.81% -7.11% 6.54% 6.29% 33.36% 16.27% 5.52%
EBITDA Growth
-4.21% -5.08% 39.39% 18.67% -20.26% -17.16% 35.73% -12.74% 54.27% 37.59% 15.83%
EBIT Growth
-3.58% -10.48% 33.66% 21.72% -27.59% -25.05% 62.15% -16.52% 39.59% 43.13% 23.60%
NOPAT Growth
2.21% -17.64% 25.29% 57.01% -23.67% -30.18% 49.45% 2.66% 24.60% 32.12% 19.08%
Net Income Growth
0.89% -23.53% 26.92% 66.36% -26.96% -36.66% 68.11% -16.86% 71.55% 46.14% 6.74%
EPS Growth
2.19% -22.46% 26.21% 65.57% -27.06% -36.65% 67.86% -16.60% 42.35% 30.82% 7.40%
Operating Cash Flow Growth
11.54% 7.11% 38.03% -14.58% 43.17% -1.79% -34.71% 10.78% 40.44% 50.90% -1.74%
Free Cash Flow Firm Growth
-21.48% -384.53% 127.64% -64.65% 463.89% -0.34% -49.10% 6.45% -1,778.78% 108.56% 9.27%
Invested Capital Growth
-2.55% 59.34% 0.89% 11.36% -4.90% -8.20% 3.15% 2.83% 157.74% 2.45% 3.30%
Revenue Q/Q Growth
-1.30% 2.75% 4.02% 2.14% -0.29% 0.04% -0.95% 3.43% 9.06% 1.64% 1.59%
EBITDA Q/Q Growth
-0.51% -1.58% 8.31% 4.50% -0.80% -2.70% -4.91% 9.67% 9.70% 0.85% 8.71%
EBIT Q/Q Growth
0.22% -7.24% 10.93% 5.37% -1.02% -3.72% -6.38% 14.75% 3.32% 0.82% 13.30%
NOPAT Q/Q Growth
5.83% -17.08% 6.90% 34.50% -20.71% 16.28% -7.93% 4.97% 22.31% -3.70% 9.00%
Net Income Q/Q Growth
5.59% -19.75% 6.45% 39.34% -21.06% 13.39% -7.58% 11.29% 23.78% 7.23% 0.74%
EPS Q/Q Growth
6.86% -19.44% 6.40% 38.99% -21.07% 13.82% -7.84% 11.36% 14.34% 4.58% 1.03%
Operating Cash Flow Q/Q Growth
9.69% 3.97% 13.95% -15.68% 29.28% -2.14% -21.80% 31.28% 12.50% 10.50% -2.51%
Free Cash Flow Firm Q/Q Growth
-19.13% -518.30% 126.35% -31.20% 23.24% 1.12% -40.02% -0.32% 3.32% -28.04% 61.50%
Invested Capital Q/Q Growth
-1.07% 53.60% -3.97% 0.76% -4.58% -4.15% 0.35% 0.91% -0.56% 1.00% -0.25%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
38.43% 38.77% 39.24% 38.91% 38.98% 37.53% 38.02% 37.74% 36.90% 37.51% 38.46%
EBITDA Margin
16.18% 14.88% 16.61% 17.82% 14.10% 12.57% 16.02% 13.15% 15.21% 18.00% 19.76%
Operating Margin
12.29% 10.82% 11.73% 12.56% 9.26% 7.53% 11.26% 11.26% 8.85% 11.78% 13.54%
EBIT Margin
12.54% 10.87% 11.64% 12.81% 9.20% 7.42% 11.30% 8.87% 9.29% 11.43% 13.39%
Profit (Net Income) Margin
9.31% 6.89% 7.01% 10.54% 7.64% 5.21% 8.22% 6.43% 8.27% 10.39% 10.51%
Tax Burden Percent
84.37% 76.47% 70.82% 93.85% 96.39% 89.12% 83.56% 80.68% 95.91% 81.88% 80.44%
Interest Burden Percent
87.99% 82.93% 85.04% 87.71% 86.13% 78.73% 87.05% 89.80% 92.84% 111.03% 97.60%
Effective Tax Rate
15.63% 23.53% 29.18% 6.15% 3.61% 10.88% 16.44% 19.32% 4.09% 18.12% 19.56%
Return on Invested Capital (ROIC)
13.96% 8.98% 9.12% 13.49% 10.02% 7.48% 11.50% 11.46% 7.88% 7.13% 8.26%
ROIC Less NNEP Spread (ROIC-NNEP)
7.57% 5.07% 5.95% 10.08% 6.27% 2.26% 6.12% -3.03% 6.39% 13.20% 2.62%
Return on Net Nonoperating Assets (RNNOA)
2.19% 3.13% 4.84% 7.22% 3.93% 1.07% 2.27% -0.91% 1.03% 1.32% 0.14%
Return on Equity (ROE)
16.15% 12.12% 13.97% 20.71% 13.95% 8.55% 13.77% 10.55% 8.90% 8.45% 8.40%
Cash Return on Invested Capital (CROIC)
16.54% -36.77% 8.23% 2.74% 15.04% 16.04% 8.39% 8.68% -80.31% 4.72% 5.01%
Operating Return on Assets (OROA)
9.65% 7.37% 8.22% 9.47% 6.47% 4.40% 6.90% 6.04% 5.68% 6.01% 7.09%
Return on Assets (ROA)
7.17% 4.67% 4.95% 7.80% 5.37% 3.09% 5.02% 4.38% 5.06% 5.46% 5.57%
Return on Common Equity (ROCE)
16.15% 12.07% 13.87% 20.60% 13.89% 8.52% 13.73% 10.52% 8.89% 8.35% 8.21%
Return on Equity Simple (ROE_SIMPLE)
16.31% 11.87% 13.18% 19.83% 13.56% 8.56% 13.27% 10.16% 5.99% 8.36% 0.00%
Net Operating Profit after Tax (NOPAT)
379 312 391 614 468 327 489 502 625 826 984
NOPAT Margin
10.37% 8.27% 8.30% 11.79% 8.93% 6.71% 9.41% 9.09% 8.49% 9.65% 10.89%
Net Nonoperating Expense Percent (NNEP)
6.39% 3.92% 3.17% 3.41% 3.74% 5.22% 5.38% 14.49% 1.48% -6.07% 5.64%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 9.32% 5.02% 6.52% 7.32%
Cost of Revenue to Revenue
61.57% 61.23% 60.76% 61.09% 61.02% 62.47% 61.98% 62.26% 63.10% 62.49% 61.54%
SG&A Expenses to Revenue
23.38% 24.24% 23.14% 22.30% 22.06% 23.44% 22.69% 22.22% 23.86% 22.32% 21.28%
R&D to Revenue
2.60% 2.92% 3.85% 3.63% 3.64% 3.84% 3.93% 3.73% 3.15% 2.69% 2.50%
Operating Expenses to Revenue
26.14% 27.95% 27.51% 26.35% 29.72% 30.00% 26.76% 26.48% 28.04% 25.73% 24.93%
Earnings before Interest and Taxes (EBIT)
458 410 548 667 483 362 587 490 684 979 1,210
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
591 561 782 928 740 613 832 726 1,120 1,541 1,785
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.83 3.70 4.52 4.05 4.55 5.93 6.51 5.55 2.67 2.64 2.88
Price to Tangible Book Value (P/TBV)
90.65 0.00 0.00 0.00 0.00 0.00 0.00 0.00 543.69 99.29 37.72
Price to Revenue (P/Rev)
1.61 2.15 2.41 2.15 2.56 3.61 4.03 3.51 3.69 3.28 3.66
Price to Earnings (P/E)
17.33 31.19 34.21 20.43 33.52 69.34 49.08 54.64 44.64 31.57 34.53
Dividend Yield
1.71% 1.37% 1.14% 1.35% 1.29% 1.06% 0.96% 1.12% 1.17% 1.25% 1.18%
Earnings Yield
5.77% 3.21% 2.92% 4.89% 2.98% 1.44% 2.04% 1.83% 2.24% 3.17% 2.90%
Enterprise Value to Invested Capital (EV/IC)
2.42 2.39 3.05 2.76 3.30 4.50 5.11 4.58 2.49 2.49 2.79
Enterprise Value to Revenue (EV/Rev)
1.78 2.70 2.79 2.54 2.87 3.86 4.25 3.68 3.86 3.41 3.74
Enterprise Value to EBITDA (EV/EBITDA)
10.98 18.16 16.79 14.27 20.33 30.71 26.51 28.02 25.41 18.97 18.92
Enterprise Value to EBIT (EV/EBIT)
14.16 24.84 23.95 19.86 31.15 52.01 37.57 41.51 41.61 29.86 27.91
Enterprise Value to NOPAT (EV/NOPAT)
17.12 32.65 33.58 21.58 32.11 57.56 45.12 40.53 45.51 35.39 34.33
Enterprise Value to Operating Cash Flow (EV/OCF)
13.98 20.49 19.14 22.60 17.93 22.85 41.00 34.13 34.00 23.15 27.22
Enterprise Value to Free Cash Flow (EV/FCFF)
14.45 0.00 37.20 106.16 21.39 26.86 61.81 53.55 0.00 53.53 56.60
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.61 1.07 0.87 0.83 0.78 1.04 0.76 0.54 0.22 0.19 0.17
Long-Term Debt to Equity
0.57 0.96 0.87 0.74 0.69 0.83 0.76 0.54 0.22 0.18 0.12
Financial Leverage
0.29 0.62 0.81 0.72 0.63 0.47 0.37 0.30 0.16 0.10 0.05
Leverage Ratio
2.25 2.59 2.82 2.66 2.60 2.77 2.75 2.41 1.76 1.55 1.51
Compound Leverage Factor
1.98 2.15 2.40 2.33 2.24 2.18 2.39 2.17 1.63 1.72 1.47
Debt to Total Capital
37.94% 51.76% 46.62% 45.34% 43.84% 50.89% 43.06% 34.92% 18.33% 15.63% 14.18%
Short-Term Debt to Total Capital
2.32% 5.68% 0.00% 5.05% 5.22% 9.90% 0.00% 0.00% 0.13% 0.29% 3.90%
Long-Term Debt to Total Capital
35.62% 46.08% 46.62% 40.29% 38.61% 40.99% 43.06% 34.92% 18.20% 15.34% 10.28%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.37% 0.34% 0.28% 0.19% 0.13% 0.14% 0.17% 0.08% 1.86% 1.96%
Common Equity to Total Capital
62.06% 47.87% 53.04% 54.38% 55.97% 48.98% 56.79% 64.91% 81.59% 82.51% 83.85%
Debt to EBITDA
2.16 4.22 2.81 2.49 3.13 5.03 2.93 2.59 2.04 1.31 1.09
Net Debt to EBITDA
1.01 3.67 2.28 2.17 2.15 1.97 1.31 1.29 1.13 0.58 0.26
Long-Term Debt to EBITDA
2.02 3.76 2.81 2.21 2.76 4.05 2.93 2.59 2.03 1.28 0.79
Debt to NOPAT
3.36 7.59 5.63 3.76 4.94 9.43 4.99 3.75 3.65 2.44 1.97
Net Debt to NOPAT
1.57 6.60 4.57 3.28 3.40 3.70 2.23 1.87 2.02 1.08 0.47
Long-Term Debt to NOPAT
3.16 6.76 5.63 3.34 4.35 7.59 4.99 3.75 3.63 2.39 1.43
Altman Z-Score
3.05 2.27 2.94 2.98 3.07 3.05 3.97 4.13 3.70 4.11 4.52
Noncontrolling Interest Sharing Ratio
0.00% 0.40% 0.70% 0.57% 0.42% 0.30% 0.26% 0.25% 0.14% 1.19% 2.25%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.44 1.49 1.88 1.51 1.63 1.80 2.27 1.89 1.76 1.75 1.63
Quick Ratio
1.74 0.93 1.25 0.96 1.17 1.43 1.65 1.28 1.20 1.19 1.13
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
449 -1,277 353 125 703 701 357 380 -6,377 546 597
Operating Cash Flow to CapEx
396.58% 404.07% 405.92% 247.26% 371.24% 450.27% 262.44% 292.16% 310.00% 398.42% 395.22%
Free Cash Flow to Firm to Interest Expense
8.16 -18.24 4.30 1.52 10.50 9.10 4.70 7.60 -130.14 12.41 20.58
Operating Cash Flow to Interest Expense
8.44 7.10 8.37 7.15 12.52 10.70 7.08 11.92 17.08 28.70 42.79
Operating Cash Flow Less CapEx to Interest Expense
6.31 5.34 6.30 4.26 9.15 8.32 4.38 7.84 11.57 21.50 31.97
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.77 0.68 0.71 0.74 0.70 0.59 0.61 0.68 0.61 0.53 0.53
Accounts Receivable Turnover
4.81 4.74 5.23 5.24 5.08 4.98 5.54 5.39 5.43 5.21 5.27
Inventory Turnover
4.89 4.84 5.47 5.69 5.65 5.55 5.12 4.59 5.12 5.31 5.62
Fixed Asset Turnover
8.12 7.15 7.48 8.02 7.99 7.42 7.99 8.67 8.19 7.38 7.82
Accounts Payable Turnover
6.65 5.81 5.69 5.61 5.42 5.22 5.33 5.05 5.50 5.42 5.51
Days Sales Outstanding (DSO)
75.94 77.05 69.75 69.64 71.87 73.32 65.90 67.72 67.24 70.02 69.22
Days Inventory Outstanding (DIO)
74.57 75.48 66.75 64.20 64.61 65.73 71.30 79.57 71.36 68.70 64.96
Days Payable Outstanding (DPO)
54.86 62.84 64.19 65.12 67.40 69.86 68.47 72.30 66.41 67.34 66.27
Cash Conversion Cycle (CCC)
95.66 89.69 72.30 68.72 69.07 69.19 68.74 74.99 72.18 71.38 67.91
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,678 4,267 4,305 4,794 4,559 4,185 4,317 4,439 11,441 11,721 12,108
Invested Capital Turnover
1.35 1.09 1.10 1.14 1.12 1.12 1.22 1.26 0.93 0.74 0.76
Increase / (Decrease) in Invested Capital
-70 1,589 38 489 -235 -374 132 122 7,002 280 387
Enterprise Value (EV)
6,486 10,186 13,127 13,244 15,044 18,828 22,056 20,341 28,459 29,234 33,776
Market Capitalization
5,892 8,109 11,325 11,218 13,442 17,611 20,957 19,396 27,184 28,099 33,044
Book Value per Share
$11.62 $12.21 $13.94 $15.40 $16.42 $16.47 $17.85 $19.39 $42.17 $43.80 $47.15
Tangible Book Value per Share
$0.36 ($9.16) ($7.98) ($8.01) ($5.86) ($5.43) ($3.27) ($0.86) $0.21 $1.16 $3.60
Total Capital
3,358 4,575 4,719 5,090 5,283 6,060 5,666 5,383 12,460 12,898 13,691
Total Debt
1,274 2,368 2,200 2,308 2,316 3,084 2,440 1,880 2,284 2,016 1,942
Total Long-Term Debt
1,196 2,108 2,200 2,051 2,040 2,484 2,440 1,880 2,268 1,978 1,408
Net Debt
594 2,060 1,786 2,012 1,592 1,209 1,091 936 1,265 895 463
Capital Expenditures (CapEx)
117 123 169 237 226 183 205 204 270 317 314
Debt-free, Cash-free Net Working Capital (DFCFNWC)
580 553 557 666 501 292 420 478 676 679 840
Debt-free Net Working Capital (DFNWC)
1,260 861 971 962 1,225 2,167 1,769 1,422 1,695 1,800 2,319
Net Working Capital (NWC)
1,182 601 971 705 949 1,567 1,769 1,422 1,679 1,762 1,785
Net Nonoperating Expense (NNE)
39 52 61 65 67 73 62 147 16 -64 34
Net Nonoperating Obligations (NNO)
594 2,060 1,786 2,012 1,592 1,209 1,091 936 1,265 839 359
Total Depreciation and Amortization (D&A)
133 151 234 261 257 251 245 236 436 562 575
Debt-free, Cash-free Net Working Capital to Revenue
15.88% 14.66% 11.83% 12.79% 9.54% 5.99% 8.08% 8.66% 9.18% 7.93% 9.30%
Debt-free Net Working Capital to Revenue
34.49% 22.83% 20.63% 18.48% 23.34% 44.44% 34.05% 25.75% 23.02% 21.02% 25.67%
Net Working Capital to Revenue
32.36% 15.94% 20.63% 13.54% 18.08% 32.14% 34.05% 25.75% 22.80% 20.58% 19.76%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.88 $1.45 $1.84 $3.05 $2.23 $1.41 $2.37 $1.97 $2.81 $3.67 $3.93
Adjusted Weighted Average Basic Shares Outstanding
180.89M 179.11M 179.63M 179.78M 180M 180.12M 180.25M 180.22M 217.01M 242.58M 243.37M
Adjusted Diluted Earnings per Share
$1.87 $1.45 $1.83 $3.03 $2.21 $1.40 $2.35 $1.96 $2.79 $3.65 $3.92
Adjusted Weighted Average Diluted Shares Outstanding
181.74M 180.04M 180.86M 181.13M 181.20M 181.10M 181.53M 180.98M 218.18M 243.52M 243.99M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
178.49M 179.47M 179.89M 179.55M 180.22M 180.36M 179.90M 180.28M 241.77M 243.05M 243.14M
Normalized Net Operating Profit after Tax (NOPAT)
384 335 409 634 672 446 495 525 698 877 1,067
Normalized NOPAT Margin
10.51% 8.88% 8.68% 12.18% 12.80% 9.14% 9.52% 9.51% 9.48% 10.24% 11.81%
Pre Tax Income Margin
11.03% 9.02% 9.90% 11.23% 7.93% 5.85% 9.84% 7.97% 8.62% 12.70% 13.07%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
8.33 5.86 6.68 8.13 7.21 4.70 7.72 9.80 13.96 22.25 41.72
NOPAT to Interest Expense
6.89 4.46 4.77 7.48 6.99 4.25 6.43 10.04 12.76 18.78 33.92
EBIT Less CapEx to Interest Expense
6.20 4.10 4.62 5.24 3.84 2.32 5.03 5.72 8.45 15.05 30.90
NOPAT Less CapEx to Interest Expense
4.76 2.70 2.71 4.59 3.62 1.87 3.73 5.96 7.25 11.57 23.10
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
30.00% 43.08% 39.39% 27.69% 43.39% 74.02% 47.54% 61.13% 49.10% 39.33% 41.16%
Augmented Payout Ratio
82.65% 44.62% 46.97% 38.43% 53.37% 98.03% 63.47% 75.77% 53.20% 41.57% 42.74%

Quarterly Metrics And Ratios for Xylem

This table displays calculated financial ratios and metrics derived from Xylem's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 243,141,405.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 243,141,405.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.79
Growth Metrics
- - - - - - - - - - -
Revenue Growth
50.43% 40.64% 40.40% 25.96% 1.35% 6.52% 1.77% 6.09% 7.79% 6.25% 2.71%
EBITDA Growth
297.70% 37.79% 76.41% 84.86% 21.39% 3.60% 7.56% 12.41% 5.95% 38.24% 4.86%
EBIT Growth
586.21% 10.89% 55.56% 104.76% 40.20% 3.57% 7.14% 19.38% 8.60% 61.21% 10.22%
NOPAT Growth
32.33% 72.09% 58.51% 106.92% 43.93% -13.15% 8.97% 14.99% 12.52% 37.62% 6.31%
Net Income Growth
1,166.67% 78.52% 54.55% 110.87% 42.76% 22.56% 9.15% 15.46% 4.15% 2.15% 13.17%
EPS Growth
800.00% 42.68% 16.67% 77.78% 41.27% 13.68% 9.52% 16.25% 4.49% 3.01% 14.49%
Operating Cash Flow Growth
84.65% 25.69% 568.42% 928.57% -16.62% 26.37% -62.92% 5.90% 15.76% -5.57% 227.27%
Free Cash Flow Firm Growth
-32,293.79% -20,320.25% -83,278.70% 105.29% 101.83% 99.29% 95.45% -197.56% -319.78% -41.11% 86.61%
Invested Capital Growth
161.56% 157.74% 148.78% -1.52% 0.86% 2.45% 4.20% 5.17% 4.59% 3.30% 1.92%
Revenue Q/Q Growth
20.56% 2.02% -4.01% 6.69% -3.00% 7.22% -8.29% 11.21% -1.43% 5.69% -11.35%
EBITDA Q/Q Growth
58.72% 4.34% -4.71% 17.15% 4.22% -10.95% -1.07% 22.43% -1.77% 16.18% -24.95%
EBIT Q/Q Growth
57.94% 12.56% -6.25% 22.86% 8.14% -16.85% -3.02% 36.89% -1.62% 23.43% -33.69%
NOPAT Q/Q Growth
63.41% 70.31% -38.96% 21.80% 13.67% 2.76% -23.41% 28.53% 11.23% 25.68% -40.83%
Net Income Q/Q Growth
65.22% 75.00% -42.48% 26.80% 11.86% 50.23% -48.77% 34.13% 0.89% 47.35% -43.24%
EPS Q/Q Growth
40.00% 85.71% -46.15% 26.98% 11.25% 49.44% -48.12% 34.78% 0.00% 47.31% -42.34%
Operating Cash Flow Q/Q Growth
1,232.14% 21.98% -80.44% 223.60% 7.99% 84.89% -94.26% 824.24% 18.03% 50.83% -80.11%
Free Cash Flow Firm Q/Q Growth
2.43% 3.10% 0.07% 105.60% -66.32% -137.74% -539.46% -20.01% 24.12% 75.77% 39.33%
Invested Capital Q/Q Growth
-1.73% -0.56% 0.74% 0.04% 0.64% 1.00% 2.47% 0.97% 0.09% -0.25% 1.09%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
36.80% 35.69% 36.99% 37.76% 37.26% 37.99% 37.12% 38.77% 38.93% 38.88% 37.79%
EBITDA Margin
16.67% 17.04% 16.92% 18.58% 19.96% 16.58% 17.88% 19.69% 19.62% 21.57% 18.26%
Operating Margin
9.20% 9.96% 10.28% 11.66% 13.31% 11.84% 11.16% 13.26% 14.73% 14.73% 11.48%
EBIT Margin
9.59% 10.58% 10.33% 11.89% 13.26% 10.28% 10.87% 13.39% 13.36% 15.60% 11.67%
Profit (Net Income) Margin
7.32% 12.56% 7.53% 8.94% 10.31% 14.45% 8.07% 9.73% 9.96% 13.89% 8.89%
Tax Burden Percent
82.16% 126.67% 78.06% 78.54% 80.67% 86.93% 76.96% 74.92% 76.09% 90.49% 77.46%
Interest Burden Percent
92.96% 93.75% 93.33% 95.74% 96.42% 161.64% 96.44% 97.08% 98.02% 98.40% 98.39%
Effective Tax Rate
17.84% -26.67% 21.94% 21.46% 19.33% 13.07% 23.04% 25.08% 23.91% 9.51% 22.54%
Return on Invested Capital (ROIC)
6.42% 11.70% 7.90% 6.62% 7.83% 7.61% 6.28% 7.33% 8.40% 10.11% 6.67%
ROIC Less NNEP Spread (ROIC-NNEP)
6.06% 11.59% 7.04% 6.30% 7.14% 16.53% 5.33% 6.88% 5.08% 12.37% 6.67%
Return on Net Nonoperating Assets (RNNOA)
1.26% 1.86% 1.21% 0.93% 0.89% 1.65% 0.57% 0.64% 0.39% 0.65% 0.59%
Return on Equity (ROE)
7.68% 13.57% 9.10% 7.55% 8.72% 9.26% 6.85% 7.96% 8.79% 10.76% 7.26%
Cash Return on Invested Capital (CROIC)
-82.94% -80.31% -76.82% 8.32% 6.57% 4.72% 3.04% 2.33% 3.11% 5.01% 6.31%
Operating Return on Assets (OROA)
5.39% 6.47% 6.88% 6.27% 6.99% 5.40% 5.76% 7.09% 7.13% 8.26% 6.33%
Return on Assets (ROA)
4.12% 7.69% 5.01% 4.71% 5.44% 7.59% 4.27% 5.16% 5.32% 7.36% 4.83%
Return on Common Equity (ROCE)
7.67% 13.55% 9.09% 7.54% 8.71% 9.15% 6.77% 7.88% 8.69% 10.52% 7.10%
Return on Equity Simple (ROE_SIMPLE)
4.95% 0.00% 6.50% 7.40% 7.84% 0.00% 8.36% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
157 267 163 199 226 232 178 228 254 319 189
NOPAT Margin
7.56% 12.62% 8.03% 9.16% 10.74% 10.29% 8.59% 9.93% 11.21% 13.33% 8.89%
Net Nonoperating Expense Percent (NNEP)
0.36% 0.12% 0.86% 0.32% 0.69% -8.92% 0.95% 0.45% 3.32% -2.27% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
- 2.15% - - - 1.83% 1.38% 1.75% 1.93% 2.38% 1.46%
Cost of Revenue to Revenue
63.20% 64.31% 63.01% 62.24% 62.74% 62.01% 62.88% 61.23% 61.07% 61.12% 62.21%
SG&A Expenses to Revenue
23.65% 22.00% 23.32% 22.36% 21.15% 22.47% 22.23% 21.86% 20.90% 20.28% 22.21%
R&D to Revenue
2.94% 2.83% 2.90% 2.67% 2.61% 2.57% 2.71% 2.52% 2.29% 2.50% 2.64%
Operating Expenses to Revenue
27.60% 25.73% 26.71% 26.10% 23.95% 26.15% 25.95% 25.51% 24.21% 24.16% 26.31%
Earnings before Interest and Taxes (EBIT)
199 224 210 258 279 232 225 308 303 374 248
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
346 361 344 403 420 374 370 453 445 517 388
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.18 2.67 3.05 3.18 3.10 2.64 2.68 2.84 3.20 2.88 2.65
Price to Tangible Book Value (P/TBV)
0.00 543.69 133.95 71.80 48.66 99.29 68.64 65.18 59.05 37.72 62.22
Price to Revenue (P/Rev)
3.21 3.69 3.91 3.92 3.89 3.28 3.38 3.61 4.04 3.66 3.20
Price to Earnings (P/E)
44.05 44.64 46.87 42.98 39.52 31.57 32.05 33.56 37.87 34.53 29.62
Dividend Yield
1.43% 1.17% 1.05% 1.02% 1.04% 1.25% 1.24% 1.18% 1.06% 1.18% 1.36%
Earnings Yield
2.27% 2.24% 2.13% 2.33% 2.53% 3.17% 3.12% 2.98% 2.64% 2.90% 3.38%
Enterprise Value to Invested Capital (EV/IC)
2.02 2.49 2.81 2.95 2.91 2.49 2.52 2.68 3.04 2.79 2.49
Enterprise Value to Revenue (EV/Rev)
3.44 3.86 4.08 4.06 4.01 3.41 3.52 3.73 4.15 3.74 3.35
Enterprise Value to EBITDA (EV/EBITDA)
22.77 25.41 25.54 23.43 22.13 18.97 19.29 20.12 22.48 18.92 16.88
Enterprise Value to EBIT (EV/EBIT)
35.12 41.61 42.70 38.24 34.82 29.86 30.41 31.17 34.56 27.91 24.69
Enterprise Value to NOPAT (EV/NOPAT)
45.48 45.51 47.20 43.20 39.41 35.39 35.94 37.32 40.90 34.33 30.61
Enterprise Value to Operating Cash Flow (EV/OCF)
31.25 34.00 34.29 28.28 29.58 23.15 25.04 26.59 29.00 27.22 23.13
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 35.25 44.55 53.53 84.63 117.90 99.89 56.60 39.82
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.23 0.22 0.22 0.19 0.19 0.19 0.18 0.18 0.17 0.17 0.17
Long-Term Debt to Equity
0.23 0.22 0.19 0.19 0.19 0.18 0.18 0.17 0.17 0.12 0.13
Financial Leverage
0.21 0.16 0.17 0.15 0.13 0.10 0.11 0.09 0.08 0.05 0.09
Leverage Ratio
1.82 1.76 1.73 1.57 1.56 1.55 1.53 1.52 1.51 1.51 1.50
Compound Leverage Factor
1.70 1.65 1.61 1.51 1.50 2.50 1.47 1.48 1.48 1.48 1.48
Debt to Total Capital
18.59% 18.33% 18.20% 16.18% 15.83% 15.63% 15.42% 15.00% 14.63% 14.18% 14.72%
Short-Term Debt to Total Capital
0.14% 0.13% 2.28% 0.14% 0.14% 0.29% 0.31% 0.51% 0.37% 3.90% 4.03%
Long-Term Debt to Total Capital
18.45% 18.20% 15.91% 16.05% 15.70% 15.34% 15.10% 14.49% 14.27% 10.28% 10.69%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.09% 0.08% 0.06% 0.06% 0.06% 1.86% 1.82% 1.77% 1.78% 1.96% 1.95%
Common Equity to Total Capital
81.32% 81.59% 81.74% 83.76% 84.11% 82.51% 82.76% 83.23% 83.59% 83.85% 83.33%
Debt to EBITDA
2.22 2.04 1.79 1.37 1.31 1.31 1.29 1.23 1.19 1.09 1.07
Net Debt to EBITDA
1.53 1.13 1.04 0.81 0.66 0.58 0.61 0.51 0.47 0.26 0.63
Long-Term Debt to EBITDA
2.21 2.03 1.56 1.36 1.29 1.28 1.26 1.19 1.17 0.79 0.78
Debt to NOPAT
4.44 3.65 3.31 2.53 2.32 2.44 2.40 2.29 2.17 1.97 1.95
Net Debt to NOPAT
3.06 2.02 1.93 1.50 1.17 1.08 1.14 0.95 0.85 0.47 1.14
Long-Term Debt to NOPAT
4.41 3.63 2.89 2.51 2.30 2.39 2.35 2.21 2.12 1.43 1.41
Altman Z-Score
2.97 3.60 4.15 4.61 4.60 3.97 4.14 4.19 4.69 4.37 4.03
Noncontrolling Interest Sharing Ratio
0.14% 0.14% 0.14% 0.09% 0.09% 1.19% 1.16% 1.12% 1.11% 2.25% 2.22%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.72 1.76 1.67 1.85 1.96 1.75 1.89 1.90 1.96 1.63 1.46
Quick Ratio
1.11 1.20 1.11 1.22 1.31 1.19 1.29 1.31 1.32 1.13 0.95
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-6,950 -6,735 -6,730 377 127 -48 -306 -368 -279 -68 -41
Operating Cash Flow to CapEx
518.06% 478.95% 121.92% 405.63% 420.27% 580.81% 50.00% 311.22% 521.74% 670.37% 121.35%
Free Cash Flow to Firm to Interest Expense
-496.43 -481.05 -480.70 34.25 12.69 -5.32 -38.28 -40.83 -46.47 -11.26 -10.25
Operating Cash Flow to Interest Expense
26.64 32.50 6.36 26.18 31.10 63.89 4.13 33.89 60.00 90.50 27.00
Operating Cash Flow Less CapEx to Interest Expense
21.50 25.71 1.14 19.73 23.70 52.89 -4.13 23.00 48.50 77.00 4.75
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.56 0.61 0.67 0.53 0.53 0.53 0.53 0.53 0.53 0.53 0.54
Accounts Receivable Turnover
5.06 5.43 5.75 5.04 5.01 5.21 5.08 4.97 5.07 5.27 5.14
Inventory Turnover
4.40 5.12 5.30 4.82 4.89 5.31 5.21 5.10 5.17 5.62 5.55
Fixed Asset Turnover
7.86 8.19 8.97 7.34 7.36 7.38 7.48 7.48 7.74 7.82 7.88
Accounts Payable Turnover
5.40 5.50 6.06 5.56 5.67 5.42 5.63 5.46 5.79 5.51 5.79
Days Sales Outstanding (DSO)
72.19 67.24 63.46 72.47 72.79 70.02 71.83 73.42 72.02 69.22 71.04
Days Inventory Outstanding (DIO)
82.94 71.36 68.85 75.68 74.57 68.70 70.04 71.53 70.62 64.96 65.83
Days Payable Outstanding (DPO)
67.54 66.41 60.20 65.64 64.34 67.34 64.78 66.79 63.05 66.27 63.01
Cash Conversion Cycle (CCC)
87.60 72.18 72.10 82.51 83.03 71.38 77.10 78.16 79.60 67.91 73.86
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
11,506 11,441 11,526 11,531 11,605 11,721 12,010 12,127 12,138 12,108 12,240
Invested Capital Turnover
0.85 0.93 0.98 0.72 0.73 0.74 0.73 0.74 0.75 0.76 0.75
Increase / (Decrease) in Invested Capital
7,107 7,002 6,893 -178 99 280 484 596 533 387 230
Enterprise Value (EV)
23,249 28,459 32,407 34,073 33,810 29,234 30,228 32,541 36,912 33,776 30,442
Market Capitalization
21,673 27,184 31,076 32,883 32,798 28,099 29,034 31,480 35,903 33,044 29,055
Book Value per Share
$41.23 $42.17 $42.15 $42.65 $43.61 $43.80 $44.50 $45.51 $46.04 $47.15 $45.13
Tangible Book Value per Share
($1.07) $0.21 $0.96 $1.89 $2.77 $1.16 $1.74 $1.98 $2.50 $3.60 $1.92
Total Capital
12,211 12,460 12,473 12,346 12,594 12,898 13,069 13,305 13,407 13,691 13,167
Total Debt
2,270 2,284 2,270 1,998 1,994 2,016 2,015 1,996 1,962 1,942 1,938
Total Long-Term Debt
2,253 2,268 1,985 1,981 1,977 1,978 1,974 1,928 1,913 1,408 1,407
Net Debt
1,565 1,265 1,323 1,183 1,005 895 956 826 771 463 1,130
Capital Expenditures (CapEx)
72 95 73 71 74 99 66 98 69 81 89
Debt-free, Cash-free Net Working Capital (DFCFNWC)
843 676 900 941 989 679 900 966 1,030 840 998
Debt-free Net Working Capital (DFNWC)
1,548 1,695 1,847 1,756 1,978 1,800 1,959 2,136 2,221 2,319 1,806
Net Working Capital (NWC)
1,531 1,679 1,562 1,739 1,961 1,762 1,918 2,068 2,172 1,785 1,275
Net Nonoperating Expense (NNE)
4.93 1.27 10 4.71 8.87 -94 11 4.49 28 -14 0.00
Net Nonoperating Obligations (NNO)
1,565 1,265 1,323 1,183 1,005 839 956 818 693 359 1,011
Total Depreciation and Amortization (D&A)
147 137 134 145 141 142 145 145 142 143 140
Debt-free, Cash-free Net Working Capital to Revenue
12.49% 9.18% 11.32% 11.21% 11.74% 7.93% 10.47% 11.07% 11.58% 9.30% 10.98%
Debt-free Net Working Capital to Revenue
22.93% 23.02% 23.24% 20.91% 23.48% 21.02% 22.78% 24.47% 24.97% 25.67% 19.87%
Net Working Capital to Revenue
22.67% 22.80% 19.65% 20.71% 23.28% 20.58% 22.31% 23.69% 24.42% 19.76% 14.02%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.63 $1.18 $0.63 $0.80 $0.89 $1.35 $0.69 $0.93 $0.93 $1.38 $0.79
Adjusted Weighted Average Basic Shares Outstanding
240.87M 217.01M 241.85M 242.57M 242.93M 242.58M 243.11M 243.40M 243.45M 243.37M 242.77M
Adjusted Diluted Earnings per Share
$0.63 $1.17 $0.63 $0.80 $0.89 $1.33 $0.69 $0.93 $0.93 $1.37 $0.79
Adjusted Weighted Average Diluted Shares Outstanding
242.19M 218.18M 243.02M 243.54M 243.75M 243.52M 243.78M 243.86M 244.09M 243.99M 243.36M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
241.08M 241.77M 242.45M 242.89M 242.94M 243.05M 243.35M 243.41M 243.47M 243.14M 237.69M
Normalized Net Operating Profit after Tax (NOPAT)
174 161 171 217 229 254 194 248 272 349 213
Normalized NOPAT Margin
8.39% 7.60% 8.41% 9.99% 10.89% 11.25% 9.37% 10.78% 11.98% 14.57% 10.02%
Pre Tax Income Margin
8.91% 9.92% 9.64% 11.39% 12.79% 16.62% 10.49% 12.99% 13.10% 15.35% 11.48%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
14.21 16.00 15.00 23.45 27.90 25.78 28.13 34.22 50.50 62.33 62.00
NOPAT to Interest Expense
11.21 19.09 11.65 18.06 22.59 25.79 22.22 25.39 42.36 53.24 47.25
EBIT Less CapEx to Interest Expense
9.07 9.21 9.79 17.00 20.50 14.78 19.88 23.33 39.00 48.83 39.75
NOPAT Less CapEx to Interest Expense
6.07 12.30 6.44 11.61 15.19 14.79 13.97 14.50 30.86 39.74 25.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
55.49% 49.10% 49.32% 43.79% 41.33% 39.33% 39.82% 39.72% 40.30% 41.16% 41.05%
Augmented Payout Ratio
57.52% 53.20% 54.15% 48.24% 45.42% 41.57% 41.81% 41.33% 41.89% 42.74% 99.18%

Financials Breakdown Chart

Key Financial Trends

Here are the key operating trends for Xylem Inc. (NYSE: XYL) over the last four years, based on the quarterly income statements, balance sheets, and cash flow statements provided.

  • Strong, multi-year revenue growth: Operating revenue rose from about $1.506B in 2022-Q4 to roughly $2.398B in 2025-Q4, a gain of about 59% across the period, signaling durable top-line momentum.
  • Gross margin remains stable: Total gross profit margins stayed in the high-30s percentage range (roughly 38-39%), indicating consistent profitability on product and service sales.
  • Operating margin improving: Operating margin firmed toward the mid-teens by 2025-Q4 (Total Operating Income around $353M on $2.40B revenue, about 14.7%), up from lower levels earlier in the period.
  • Net income trending higher: Net income attributable to common shareholders increased from roughly $149M (2022-Q4) to about $335M (2025-Q4), reflecting stronger profitability.
  • Per-share earnings rising: Basic EPS reached about $1.38 and Diluted EPS about $1.37 in 2025-Q4, up from earlier quarters, signaling improved profitability per share.
  • Cash flow from operations remains robust: Net cash from continuing operating activities was about $543M in 2025-Q4, implying solid cash conversion relative to net income.
  • Solid balance sheet scale and leverage: Total assets ≈ $17.3B and total equity ≈ $11.2B with total liabilities ≈ $5.8B (as of recent quarters), yielding a moderate leverage profile (debt-to-equity around 0.5).
  • Large goodwill and intangible asset base: Goodwill around $8–9B and intangible assets in the low-to-mid billions across periods, creating potential impairment considerations in downturns.
  • Investing cash outflows persist: Net cash from investing activities has been negative in recent periods (e.g., about -$142M in 2025-Q4), reflecting ongoing capital expenditures and investments.
  • Cash outflows from financing continue: Net cash from financing activities were negative across periods due to dividend payments and share-related activities, reducing cash balances over time.
05/08/26 07:21 PM ETAI Generated. May Contain Errors.

Xylem Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Xylem's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Xylem's net income appears to be on an upward trend, with a most recent value of $950 million in 2025, rising from $340 million in 2015. The previous period was $890 million in 2024. Check out Xylem's forecast to explore projected trends and price targets.

Xylem's total operating income in 2025 was $1.22 billion, based on the following breakdown:
  • Total Gross Profit: $3.48 billion
  • Total Operating Expenses: $2.25 billion

Over the last 10 years, Xylem's total revenue changed from $3.65 billion in 2015 to $9.04 billion in 2025, a change of 147.3%.

Xylem's total liabilities were at $5.89 billion at the end of 2025, a 4.9% increase from 2024, and a 128.7% increase since 2015.

In the past 10 years, Xylem's cash and equivalents has ranged from $296 million in 2018 to $1.88 billion in 2020, and is currently $1.48 billion as of their latest financial filing in 2025.

Over the last 10 years, Xylem's book value per share changed from 11.62 in 2015 to 47.15 in 2025, a change of 305.8%.



Financial statements for NYSE:XYL last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners